129 related articles for article (PubMed ID: 1591370)
1. The use of protein A columns in the treatment of cancer and allied diseases.
Ciavarella D
Int J Clin Lab Res; 1992; 21(3):210-3. PubMed ID: 1591370
[TBL] [Abstract][Full Text] [Related]
2. Life-threatening reaction to staphylococcal protein A immunomodulation.
Smith RE; Gottschall JL; Pisciotta AV
J Clin Apher; 1992; 7(1):4-5. PubMed ID: 1592851
[No Abstract] [Full Text] [Related]
3. Evidence for proteolytic cleavage of covalently bound protein A from a silica based extracorporeal immunoadsorbent and lack of relationship to treatment effects.
Balint JP; Jones FR
Transfus Sci; 1995 Mar; 16(1):85-94. PubMed ID: 10155709
[TBL] [Abstract][Full Text] [Related]
4. Specificity of antibody responses affected by extracorporeal immunoadsorption of plasma over columns of protein A silica.
Snyder HW; Seawell BW; Cochran SK; Balint JP; Jones FR
J Clin Apher; 1992; 7(3):110-8. PubMed ID: 1337544
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma.
Snyder HW; Mittelman A; Oral A; Messerschmidt GL; Henry DH; Korec S; Bertram JH; Guthrie TH; Ciavarella D; Wuest D
Cancer; 1993 Mar; 71(5):1882-92. PubMed ID: 8448753
[TBL] [Abstract][Full Text] [Related]
6. Correcting immune imbalance: the use of Prosorba column treatment for immune disorders.
Levy J; Degani N
Ther Apher Dial; 2003 Apr; 7(2):197-205. PubMed ID: 12918943
[TBL] [Abstract][Full Text] [Related]
7. Treatment of patients with HIV thrombocytopenia and hemolytic uremic syndrome with protein A (Prosorba column) immunoadsorption.
Mittelman A; Bertram J; Henry DH; Snyder HW; Messerschmidt GL; Ciavarella D; Ainsworth S; Kiprov D; Arlin Z
Semin Hematol; 1989 Apr; 26(2 Suppl 1):15-8. PubMed ID: 2658095
[TBL] [Abstract][Full Text] [Related]
8. Transfusion medicine 1994.
Pineda A; Korbling M; Rock GA
Rev Invest Clin; 1994 Apr; Suppl():101-15. PubMed ID: 7886293
[No Abstract] [Full Text] [Related]
9. Modulation of immunity in patients with autoimmune disease and cancer treated by extracorporeal immunoadsorption with PROSORBA columns.
Snyder HW; Balint JP; Jones FR
Semin Hematol; 1989 Apr; 26(2 Suppl 1):31-41. PubMed ID: 2543085
[TBL] [Abstract][Full Text] [Related]
10. Leukocytoclastic vasculitis following staphylococcal protein A column immunoadsorption therapy for idiopathic thrombocytopenic purpura.
Bourelly PE; Grossman ME
Cutis; 1999 Oct; 64(4):250-2. PubMed ID: 10544880
[TBL] [Abstract][Full Text] [Related]
11. The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndrome.
Mistry B; Kimmel PL; Hetzel PC; Phillips TM; Braden GL
Am J Kidney Dis; 2004 Oct; 44(4):e50-8. PubMed ID: 15384034
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-associated hemolytic-uremic syndrome. Successful treatment with a staphylococcal protein A column.
Watson PR; Guthrie TH; Caruana RJ
Cancer; 1989 Oct; 64(7):1400-3. PubMed ID: 2528403
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo perfusion of plasma over protein A columns in human mammary adenocarcinoma. Role of the Fc-binding capacity of protein A in the side effects and the tumoricidal response.
Kinet JP; Bensinger WI; Balland N; Saint-Remy M; Frankenne F; Hennen G; Mahieu P
Eur J Clin Invest; 1986 Feb; 16(1):50-5. PubMed ID: 3084273
[TBL] [Abstract][Full Text] [Related]
14. Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients.
Karpatkin S; Nardi MA; Hymes KB
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2263-7. PubMed ID: 7892259
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial of plasma perfusion over immobilized staphylococcal protein A in metastatic breast cancer.
Ventura GJ; Buzdar AU; Kau S; Lichtiger B; Hortobagyi GN
Cancer Treat Rep; 1987 Apr; 71(4):411-3. PubMed ID: 3548958
[TBL] [Abstract][Full Text] [Related]
16. Immune thrombocytopenia purpura: a pilot study of staphylococcal protein A immunomodulation in refractory patients.
Guthrie TH; Oral A
Semin Hematol; 1989 Apr; 26(2 Suppl 1):3-9. PubMed ID: 2727721
[TBL] [Abstract][Full Text] [Related]
17. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.
Fennelly DW; Norton L; Sznol M; Hakes TB
Cancer; 1995 Apr; 75(8):2099-102. PubMed ID: 7697600
[TBL] [Abstract][Full Text] [Related]
19. Modulation of idiotypic and antiidiotypic immunoglobulin G responses in an immune thrombocytopenic purpura patient as a consequence of extracorporeal protein A immunoadsorption.
Balint JP; Cochran SK; Jones FR
Artif Organs; 1995 Jun; 19(6):496-9. PubMed ID: 8526787
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials with staphylococcal protein A.
Bensinger WI; Buckner CD; Clift RA; Thomas ED
J Biol Response Mod; 1984; 3(3):347-51. PubMed ID: 6379119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
